bq 610 has been researched along with fluoxetine in 1 studies
| Studies (bq 610) | Trials (bq 610) | Recent Studies (post-2010) (bq 610) | Studies (fluoxetine) | Trials (fluoxetine) | Recent Studies (post-2010) (fluoxetine) |
|---|---|---|---|---|---|
| 124 | 1 | 3 | 10,100 | 1,663 | 3,263 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianciotti, LG; Hope, SI; Nabhen, SL; Soria, C; Vatta, MS | 1 |
1 other study(ies) available for bq 610 and fluoxetine
| Article | Year |
|---|---|
Endothelin-1 and -3 modulate the neuronal norepinephrine transporter through multiple signalling pathways in the rat posterior hypothalamus.
Topics: Adenylyl Cyclases; Animals; Cyclic AMP-Dependent Protein Kinases; Endothelin-1; Endothelin-3; Enzyme Activation; Fluoxetine; Hypothalamus, Posterior; Male; Neurons; Nitric Oxide; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Oligopeptides; Piperidines; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction | 2010 |